share_log

Butterfly Network | 10-K: FY2023 Annual Report

Butterfly Network | 10-K: FY2023 Annual Report

Butterfly Network | 10-K:2023財年年報
美股SEC公告 ·  03/04 20:05

牛牛AI助理已提取核心訊息

Butterfly Network, a digital health company specializing in portable ultrasound technology, reported a decrease in product revenue by 20.3% to $40.036 million in 2023 from $50.263 million in 2022. Software and other services revenue, however, increased by 11.8% to $25.864 million in 2023. The company's total revenue fell by 10.2% to $65.9 million in 2023 from $73.39 million in the previous year. Despite the revenue decline, Butterfly Network managed to reduce its operating expenses significantly. Research and development expenses dropped by 36.8%, sales and marketing by 34.3%, and general and administrative expenses by 36.1%. The company's net loss widened to $133.7 million in 2023, a 202.9% loss as a percentage of revenue, compared to a 229.9% loss in 2022. Butterfly Network has taken actions to reduce operational costs and extend its cash runway, expecting its cash to last...Show More
Butterfly Network, a digital health company specializing in portable ultrasound technology, reported a decrease in product revenue by 20.3% to $40.036 million in 2023 from $50.263 million in 2022. Software and other services revenue, however, increased by 11.8% to $25.864 million in 2023. The company's total revenue fell by 10.2% to $65.9 million in 2023 from $73.39 million in the previous year. Despite the revenue decline, Butterfly Network managed to reduce its operating expenses significantly. Research and development expenses dropped by 36.8%, sales and marketing by 34.3%, and general and administrative expenses by 36.1%. The company's net loss widened to $133.7 million in 2023, a 202.9% loss as a percentage of revenue, compared to a 229.9% loss in 2022. Butterfly Network has taken actions to reduce operational costs and extend its cash runway, expecting its cash to last into 2026. The company plans to seek additional capital to reach profitability before 2026, prioritizing non-dilutive capital initially. Butterfly Network's business development includes the marketing and sale of its ultrasound system, which comprises probes, accessories, and software subscriptions, to healthcare providers. The company's future plans involve continued investment to grow revenue, with a focus on expanding its software offerings and developing relationships with larger healthcare systems.
數字醫療公司Butterfly Network專門從事便攜式超聲技術,其產品營業收入在2023年下降20.3%,從2022年的5,026.3萬元降至4,003.6萬元。然而,軟件和其他服務的營業收入在2023年增長了11.8%,達到2,586.4萬元。該公司的總營業收入從2022年的7,339萬元下降到2023年的6,590萬元,下降了10.2%。儘管營收下降,Butterfly Network成功地顯著降低了其營業費用。研發費用下降了36.8%,銷售和營銷費用下降了34.3%,一般和管理費用下降了36.1%。該公司的淨虧損在2023年擴大至1.337億元,收入的比例損失達到202.9%,而2...展開全部
數字醫療公司Butterfly Network專門從事便攜式超聲技術,其產品營業收入在2023年下降20.3%,從2022年的5,026.3萬元降至4,003.6萬元。然而,軟件和其他服務的營業收入在2023年增長了11.8%,達到2,586.4萬元。該公司的總營業收入從2022年的7,339萬元下降到2023年的6,590萬元,下降了10.2%。儘管營收下降,Butterfly Network成功地顯著降低了其營業費用。研發費用下降了36.8%,銷售和營銷費用下降了34.3%,一般和管理費用下降了36.1%。該公司的淨虧損在2023年擴大至1.337億元,收入的比例損失達到202.9%,而2022年的比例損失爲229.9%。Butterfly Network採取行動來降低運營成本並擴展其現金運營時間,預計其現金可以維持到2026年。該公司計劃尋求額外資金,在2026年之前實現盈利,並優先考慮非稀釋性資本。Butterfly Network的業務發展包括向醫療服務提供商營銷和銷售其超聲系統,包括探針、附件和軟件訂閱。該公司未來的計劃涉及持續投資以增加收入,重點是擴大其軟件業務,並與更大的醫療系統建立關係。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。